Sana Biotechnology, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sana Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Sana Biotechnology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$61.8M, a 2732% decline year-over-year.
  • Sana Biotechnology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$312M, a 9.91% decline year-over-year.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$293M, a 7.55% decline from 2022.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$273M, a 23.6% increase from 2021.
  • Sana Biotechnology, Inc. annual Operating Income (Loss) for 2021 was -$357M, a 24.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$293M -$20.6M -7.55% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$273M +$84.3M +23.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$357M -$70.8M -24.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$286M -$145M -103% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 -$141M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.